OVARIAN CANCER MANIFESTED BY MESENTERIC AND HEPATIC VENOUS THROMBOSIS
- 作者: Magdebura Y.1, Solopova A.2
-
隶属关系:
- S.P. Botkin City Clinical Hospital
- I.M. Sechenov First Moscow State Medical University
- 期: 卷 27, 编号 11 (2016)
- 页面: 61-65
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116826
- ID: 116826
如何引用文章
详细
The paper describes a case of nonspecific manifestation of ovarian cancer, which reflects the typical complexities of a clinical search and the possible variants of increasing the informative value of studies to make an accurate diagnosis.
全文:
作者简介
Yu. Magdebura
S.P. Botkin City Clinical Hospital
A. Solopova
I.M. Sechenov First Moscow State Medical University
Email: dr.solopova@mail.ru
Candidate of Medical Sciences
参考
- Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой / М.: МНИОИ им. П.А. Герцена, 2016.
- Prat J. Staging classification for cancer of the ovary, fallopian tube and peritoneum // Intern. J. Gynecol. Obstet. - 2014; 124 (1): 1-5.
- Siegel R., Ma J., Zou Z. et al. Cancer statistics, 2014 / CA: A Cancer Journal for Clinicians, 2014; 64.
- SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda. Avaible online at http://seer.cancer.gov/statfacts/html/ovary.html
- American Cancer Society. Cancer Facts & Figures 2016 / Atlanta: American Cancer Society, 2016.
- Mohaghegh P., Rockall A. Imaging Strategy for Early Ovarian Cancer: Characterization of Adnexal Masses with Conventional and Advanced Imaging Techniques // Radiographics. - 2012; 32 (6): doi: 10.1148/326125520.
- Бахтиозин Р.Ф., Сафиуллин Р.Р. Диффузионно-взвешенное изображение всего тела в диагностике онкологических заболеваний // Кубанский научный медицинский вестник. - 2010; 6: 16-20.
- Falanga A. Mechanism of hypercoagulation in malignancy and during chemotherapy // Haemostasis. - 1998; 28 (3): 50-60.
- Воробьев А.В., Макацария А.Д. Тромбофилия, тромбозы и антитромботическая терапия у онкологических больных // Акушерство, гинекология и репродукция. - 2014; 2: 139-48.
- Zhao T., Hu W. CA125 and HE4: Measurement Tools for Ovarian Cancer // Gynecol. Obstet. Invest. - 2016; doi: 10.1159/000442288.
- Anton C., Carvalho F., Oliveira E. et al. A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses // Clinics. - 2012; 67: 437-41. doi: 10.6061/clinics/2012(05)06.
- Harris R., Javitt M., Glanc Ph. et al. Clinically Suspected Adnexal Mass / ACR Appropriateness Criteria®, 2012.
- Forstner R. et al. ESUR guidelines: ovarian cancer staging and follow-up // Eur. Radiol. - 2010; 20: 2773-3780.
- Kaijser J., Bourne T., Valentin L. et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies // Ultrasound Obstet. Gynecol. - 2013; 41: 9-20.
- Spencer J. et al. ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach // Eur. Radiology. - 2010; 20: 25-35. doi: 10.1007/s00330-009-1584-2.
- Adusumilli S., Hussain H., Caoili E. et al. MRI of sonographically indeterminate adnexal masses // AJR Am. J. Roentgenol. - 2006; 187: 732-40.
- Sohaib S., Mills T., Sahdev A. et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses // Clin. Radiol. - 2005; 60: 340-8.
- Солопова А.Е., Чащин А.А., Солопова А.Г. и др. Современные взгляды на патогенез и возможности диагностики эпителиального рака яичников // Акушерство, гинекология и репродукция. - 2016; 10 (1): 75-83.